Tradestie Institutional Equity Comparison Engine

BOLD vs EDGE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BOLD Overall Edge

BOLD Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boundless Bio, Inc. Common Stock (BOLD) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, BOLD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus EDGE at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EDGE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BOLD N/M vs EDGE N/M Fwd P/E
Growth & Margin Winner BOLD
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner BOLD
1Y +101.7% vs +3.6% ยท 52W Pos 62% vs 35%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BOLD NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap $56.2M
1M Return -4.92%
1Y Return +101.74%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 25.0 Fund 50.0 Flow 50.0 Mom 60.0
EDGE US Equity
EDGE
Institutional Equity
$46.01
-4.8% 1D
Market Cap N/A
1M Return -11.47%
1Y Return +3.56%
Forward P/E N/M
Unified AI Score
43.7 / 100 HOLD
Tech 28.0 Fund 48.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BOLD +101.74% EDGE +3.56% Spread: +95.64 pp (BOLD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BOLD TTM Op. Margin: 0.0% EDGE TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BOLD vs EDGE. Trailing 12-month operating profitability (BOLD 0.0% vs EDGE N/A) and valuation multiples (BOLD N/M vs EDGE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BOLD (6) vs EDGE (2)
Institutional Metric BOLD EDGE Criterion Row Winner
Market Capitalization Scale $56.2M N/A Larger Scale BOLD
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth BOLD
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin BOLD
Net Profit Margin Profitability 0.0% N/A Higher Margin BOLD
Return on Equity (ROE) Capital Efficiency -64.6% N/A Higher ROE BOLD
52-Week Range Position Momentum 62% ($1โ€“$3) 35% ($42โ€“$53) Stronger Trend BOLD
Beta / 30D Volatility Risk Regime -0.08ฮฒ ยท 28% Vol 0.98ฮฒ ยท 27% Vol Lower Realized Risk EDGE
Unified Institutional Score Composite Signal 36.8 / 100 (SELL) 43.7 / 100 (HOLD) Higher Composite EDGE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BOLD vs EDGE Buy Guide
BOLD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BOLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EDGE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EDGE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BOLD nor EDGE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.